Media Centre
Latest press releases
-
Calquence significantly prolonged the time patients lived without disease progression or death in previously untreated chronic lymphocytic leukaemia
-
Lynparza approved in China as a 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
AstraZeneca divests rights to Seroquel and Seroquel XR in the US and Canada
-
Imfinzi granted FDA Priority Review for the treatment of patients with extensive-stage small cell lung cancer
-
Calquence approved in the US for adult patients with chronic lymphocytic leukaemia
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Rebecca Einhorn
Director Global Media Relations
Jennifer Hursit
Manager Global Media Relations
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
